00:46 IST
NSE
Management Change
Avience Biomedicals Management Change
Avience Biomedicals Limited has appointed M/s. G.R. Gupta and Associates as the new Secretarial Auditor of the company for a term of 60 months.
Avience Biomedicals Ltd
- Share price
- ₹294.00
- Market cap
- ₹161.3 Cr
- Revenue (annual)
- ₹52.51 Cr
- Net profit (annual)
- ₹8.75 Cr
- P/E (TTM)
- 18.4×Sector 53.1×
- Promoter holding
- 64.59%
- FII holding
- 3.06%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 2Earnings Call 2Annual General Meeting 2Management Change 1Financial Results 1Board Meeting Outcome 1
Time
1 announcement with these filters